Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

K2M's Chesapeake lumbar stabilisation system cleared in US

This article was originally published in Clinica

Executive Summary

Chesapeake, an anterior lumbar stabilisation system developed by spinal specialist K2M (Leesburg, Virginia), has received 510(k) clearance from the US FDA. The device is designed to stabilise the spine in patients suffering from disorders such as degenerative disc disease. The screws in the system use K2M's tifix locking technology, forming an autogenic lock to the implant upon insertion, which simplifies the implantation procedure. Chesapeake is made from the biocompatible Peek polymer.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT095550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel